Answers in CME

CME in Minutes: Education in Oncology & Hematology

迅速にトップ専門家からの洞察を得て、腫瘍学者や血液学者向けの魅力的なプログラムでCME/CEクレジットを獲得しましょう。重要な進展や症例研究について最新情報を入手してください。

Listen on Apple Podcasts

Jesus G. Berdeja, MD - Optimizing Outcomes in Relapsed/Refractory Multiple Myeloma With Bispecific Antibodies: A Community Clinician's Roadmap

17 mins • May 6, 2025

最近のエピソード

May 6, 2025

Jesus G. Berdeja, MD - Optimizing Outcomes in Relapsed/Refractory Multiple Myeloma With Bispecific Antibodies: A Community Clinician's Roadmap

17 mins

Apr 16, 2025

Aditya Bardia, MD / Sara Hurvitz, MD - Making a World of Difference for Patients With HER2-Low and -Ultralow Advanced Breast Cancer: Practical Strategies to Integrate Antibody-Drug Conjugates in Special Populations

30 mins

Apr 10, 2025

Komal Jhaveri, MD, FACP - Opportunities to Personalize Care: Making the Case for TROP2-Directed ADCs in HR+, HER2- Metastatic Breast Cancer

19 mins

Apr 10, 2025

Aditya Bardia, MD / Sara Hurvitz, MD - Realizing the Potential of Antibody-Drug Conjugates in HER2-Low and -Ultralow Advanced Breast Cancer: Evolving Strategies to Individualize Care

26 mins

Apr 4, 2025

Aditya Bardia, MD / Marilyn M. Bui, MD, PhD - Bringing HER2 Low and Ultralow to Light: How to Define and Detect HER2 Status in Advanced Breast Cancer

22 mins

言語
英語
アメリカ合衆国
ウェブサイト
フィード
更新をリクエストする
更新には数分かかる場合があります。